Gabapentin
Product Images NDC 60760-864

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 60760-864). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 01)

Chemical structure of Gabapentin, showing its cyclohexane ring attached to amino and carboxyl functional groups.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 02)

A line graph showing mean pain score over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The timeline includes a 4-week dose titration period followed by a 4-week fixed dose period, with pain scores decreasing more significantly in the Gabapentin group than placebo.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 03)

A line graph showing mean pain score over 7 weeks with three groups: placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks from baseline to week 7, and the y-axis shows pain scores from 0 to 10. Two study phases are indicated: a 3-week dose titration period and a 4-week fixed dose period.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 04)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing response rates in two studies. Study 1 shows 12% responders for placebo (PBO) and 29% for Gabapentin 3600 mg (GBP 3600). Study 2 shows 14% for placebo, 32% for Gabapentin 1800 mg, and 34% for Gabapentin 2400 mg. Statistical significance levels are indicated with * for p < 0.01 and *** for p < 0.001.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 05)

A scatter plot chart showing the percentage difference on the y-axis versus daily dose in mg on the x-axis for Gabapentin. It compares three studies (labeled study a, study b, and study c) with data points at various daily doses ranging from approximately 600 mg to 1800 mg.*

FDA Label Image

864-90 (Gabapentin 60760 864 90)

Gabapentin Capsules, USP 400 mg label showing quantity of 90 capsules. The label includes the NDC 60760-864-90, lot number EF0068F, and expiration date 04-26. Manufactured by Graviti Pharmaceuticals Pvt. Ltd., India, and packaged by St. Mary's Medical Park Pharmacy in Oro Valley, AZ. Storage instructions note controlled room temperature (15°-30°C).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.